Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹21 Cr
Revenue (TTM)
₹5 Cr
Net Profit (TTM)
₹0 Cr
ROE
2.6 %
ROCE
2.7 %
P/E Ratio
53.2
P/B Ratio
2.1
Industry P/E
48.17
EV/EBITDA
39.1
Div. Yield
0 %
Debt to Equity
0
Book Value
₹--
EPS
₹0.6
Face value
10
Shares outstanding
6,272,629
CFO
₹17.48 Cr
EBITDA
₹-10.48 Cr
Net Profit
₹4.44 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pentokey Organy
| -18.6 | -17.4 | -18.6 | 4.5 | -7.3 | 24.9 | -- |
|
BSE Healthcare*
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pentokey Organy
| -17.1 | -55.1 | 378.5 | -1.9 | 281.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pentokey Organy
|
33.1 | 20.7 | 4.6 | 0.4 | 1.7 | 4 | 53.2 | 2.1 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 1,249.1 | 5,435.2 | 6,020.3 | 132.1 | 3.2 | 6.8 | 48.2 | 3.0 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 30.5 | 13.4 | 25.3 | 0.1 | 0.4 | 2.5 | 117.7 | 2.8 | |
| 24.1 | 30.1 | 16.0 | -4.4 | -58.4 | -3.7 | -- | 0.3 | |
| 43.5 | 23.8 | 294.6 | 2.1 | 0.9 | 163.8 | 11.6 | 9.3 | |
| 1.9 | 7.6 | 110.0 | -0.2 | 0.0 | -3.5 | -- | 1.6 | |
| 0.3 | 30.9 | 386.8 | 35.4 | 11.1 | 29.9 | 0.9 | 0.2 |
No Review & Analysis are available.
Pentokey Organy (India) Limited trades in organic chemicals. Its products include acetic acid, ethyl acetate, acetaldehyde, and butyl acetate. Pentokey Organy (India) Limited was incorporated in 1986 and is headquartered in Mumbai, India.
Incorporated
1986
Chairman
--
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Pentokey Organy (India) Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Pentokey Organy (India) Ltd is ₹33.06 (BSE) as of 01-Apr-2026 IST. Pentokey Organy (India) Ltd has given a return of -7.28% in the last 3 years.
The P/E ratio of Pentokey Organy (India) Ltd is 53.17 times as on 01-Apr-2026, a 10 premium to its peers’ median range of 48.17 times.
The P/B ratio of Pentokey Organy (India) Ltd is 2.09 times as on 01-Apr-2026, a 704 premium to its peers’ median range of 0.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
80.86
|
2.10
|
|
2024
|
40.26
|
3.79
|
|
2023
|
8.19
|
3.11
|
|
2022
|
0.00
|
2.18
|
|
2021
|
0.00
|
1.27
|
The 52-week high and low of Pentokey Organy (India) Ltd are Rs 63.99 and Rs 28.49 as of 02-Apr-2026.
Pentokey Organy (India) Ltd has a market capitalisation of ₹ 21 Cr as on 01-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Pentokey Organy (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.94
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.